Entry - #610188 - JOUBERT SYNDROME 5; JBTS5 - OMIM
# 610188

JOUBERT SYNDROME 5; JBTS5


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
12q21.32 Joubert syndrome 5 610188 AR 3 CEP290 610142
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
HEAD & NECK
Eyes
- Congenital amaurosis
- Tapetoretinal degeneration
- Nystagmus
- Retinal coloboma
- Oculomotor apraxia
RESPIRATORY
- Neonatal breathing dysregulation
- Hyperpnea, episodic
- Tachypnea, episodic
- Central apnea
GENITOURINARY
Kidneys
- Cortical cysts
- Nephronophthisis
- Urine concentration defect
- End stage renal disease
NEUROLOGIC
Central Nervous System
- Hypotonia
- Mental retardation
- Cerebellar vermis aplasia/hypoplasia
- Ataxia
- 'Molar tooth sign'
- Thick, maloriented superior cerebellar peduncles
- Deep interpeduncular fossa
MISCELLANEOUS
- Allelic to Senior-Loken syndrome 6 (610189) and Leber congenital amaurosis type X (610142)
MOLECULAR BASIS
- Caused by mutation in the 290-kD centrosomal protein gene (CEP290, 610142.0004)
Joubert syndrome - PS213300 - 43 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.32 Joubert syndrome 25 AR 3 616781 CEP104 616690
2q13 Joubert syndrome 4 AR 3 609583 NPHP1 607100
2q33.1 Joubert syndrome 14 AR 3 614424 TMEM237 614423
2q37.1 Joubert syndrome 30 AR 3 617622 ARMC9 617612
2q37.1 Joubert syndrome 22 AR 3 615665 PDE6D 602676
3q11.1-q11.2 Joubert syndrome 8 AR 3 612291 ARL13B 608922
4p15.32 Joubert syndrome 9 AR 3 612285 CC2D2A 612013
5p13.2 Joubert syndrome 17 AR 3 614615 CPLANE1 614571
5q23.2 Joubert syndrome 31 AR 3 617761 CEP120 613446
6q23.3 Joubert syndrome 3 AR 3 608629 AHI1 608894
7q32.2 Joubert syndrome 15 AR 3 614464 CEP41 610523
8q13.1-q13.2 Joubert syndrome 21 AR 3 615636 CSPP1 611654
8q22.1 Joubert syndrome 6 AR 3 610688 TMEM67 609884
9p21.2 Joubert syndrome 40 AR 3 619582 IFT74 608040
9q34.3 Joubert syndrome 1 AR 3 213300 INPP5E 613037
10q22.2 Joubert syndrome 36 AR 3 618763 FAM149B1 618413
10q24.1 Joubert syndrome 18 AR 3 614815 TCTN3 613847
10q24.32 Joubert syndrome 32 AR 3 617757 SUFU 607035
10q24.32 Joubert syndrome 35 AR 3 618161 ARL3 604695
11q12.2 Joubert syndrome 16 AR 3 614465 TMEM138 614459
11q12.2 Joubert syndrome 2 AR 3 608091 TMEM216 613277
11q24.2 Joubert syndrome 39 AR 3 619562 TMEM218 619285
12q21.32 Joubert syndrome 5 AR 3 610188 CEP290 610142
12q24.11 Joubert syndrome 13 AR 3 614173 TCTN1 609863
12q24.31 Joubert syndrome 24 AR 3 616654 TCTN2 613846
13q21.33-q22.1 Joubert syndrome 33 AR 3 617767 PIBF1 607532
14q21.2 Joubert syndrome 37 AR 3 619185 TOGARAM1 617618
14q23.1 Joubert syndrome 23 AR 3 616490 KIAA0586 610178
15q26.1 Acrocallosal syndrome AR 3 200990 KIF7 611254
15q26.1 Joubert syndrome 12 AR 3 200990 KIF7 611254
16p12.1 Joubert syndrome 26 AR 3 616784 KATNIP 616650
16q12.1 Joubert syndrome 19 AD, AR 3 614844 ZNF423 604557
16q12.1 Nephronophthisis 14 AD, AR 3 614844 ZNF423 604557
16q12.2 Joubert syndrome 7 AR 3 611560 RPGRIP1L 610937
16q23.1 Joubert syndrome 20 AR 3 614970 TMEM231 614949
17p13.1 ?Joubert syndrome 38 AR 3 619476 KIAA0753 617112
17p13.1 ?Joubert syndrome 29 AR 3 617562 TMEM107 616183
17p13.1 Meckel syndrome 13 AR 3 617562 TMEM107 616183
17p11.2 Joubert syndrome 27 AR 3 617120 B9D1 614144
17q22 Joubert syndrome 28 AR 3 617121 MKS1 609883
19q13.2 Joubert syndrome 34 AR 3 614175 B9D2 611951
19q13.2 ?Meckel syndrome 10 AR 3 614175 B9D2 611951
Xp22.2 Joubert syndrome 10 XLR 3 300804 OFD1 300170

TEXT

A number sign (#) is used with this entry because of evidence that Joubert syndrome-5 (JBTS5) is caused by homozygous or compound heterozygous mutation in the gene encoding the centrosomal protein CEP290 (610142) on chromosome 12q21.

For a phenotypic description and a discussion of genetic heterogeneity of Joubert syndrome, see 213300.


Clinical Features

Joubert syndrome (JBTS) is an autosomal recessive disorder presenting with psychomotor delay, hypotonia, ataxia, oculomotor apraxia, and neonatal breathing abnormalities (Valente et al., 2006). Neuroradiologically, Joubert syndrome is characterized by a peculiar malformation of the midbrain-hindbrain junction known as the 'molar tooth sign' (MTS) consisting of cerebellar vermis hypoplasia or aplasia, thick and maloriented superior cerebellar peduncles, and abnormally deep interpeduncular fossa. A number of distinct syndromes sharing the MTS have been described, presenting wide phenotypic variability both within and among families (Gleeson et al., 2004).

Valente et al. (2006) described the JBTS5 phenotype as characterized mainly by the neurologic and neuroradiologic features of Joubert syndrome associated with severe retinal and renal involvement, but noted that the clinical spectrum was broad, including incomplete phenotypes such as cerebelloretinal and cerebellorenal syndromes. The full-blown JBTS5 phenotype largely overlaps that of Senior-Loken syndrome (SLSN; see 266900), which is characterized by retinitis pigmentosa plus juvenile nephronophthisis and is attributable to mutations in genes associated with nephronophthisis and encoding ciliary proteins.

In a comprehensive study of 279 patients from 232 unrelated families with Joubert syndrome in whom a genetic basis was determined by molecular analysis of 27 candidate genes, Bachmann-Gagescu et al. (2015) found a significant association between mutations in the CEP290 gene and retinal dystrophy (odds ratio (OR) of 22.9) and cystic kidney disease (OR of 3.3). None of 55 individuals with CEP290 mutations had seizures, suggesting a negative association with that feature.


Inheritance

The transmission pattern of JBTS5 in the families reported by Sayer et al. (2006) was consistent with autosomal recessive inheritance.


Mapping

In Joubert syndrome, nephronophthisis (NPHP) is combined with retinal degeneration, cerebellar vermis aplasia, and mental retardation. Identification of 5 genes mutated in NPHP implicated primary cilia, basal bodies, and mechanisms of plantar cell polarity in the pathogenesis of renal cystic disease. In a worldwide cohort including 90 individuals with JBTS, recessive mutations in known NPHP-associated genes were found in only 1% of JBTS cases (Utsch et al., 2006). To identify further causative genes for NPHP, Sayer et al. (2006) performed a whole-genome search for linkage by homozygosity mapping in 25 consanguineous kindreds with NPHP, SLSN, or JBTS, ascertained worldwide, each of which had 2 affected individuals and was negative for mutations in known NPHP genes. Three kindreds showed an overlap of nonparametric lod score (NPL) peaks on 12q indicating potential homozygosity by descent. Refinement of the linkage narrowed the region to 12q21.32-q21.33.

Valente et al. (2006) identified the JBTS5 locus on 12q21.31-q21.33 in linkage analysis from consanguineous families with Joubert syndrome-related disorders (JSRDs), which showed the neurologic features of Joubert syndrome associated with multiorgan involvement (mainly retinal dystrophy and nephronophthisis).

Identification of causative mutations in the CEP290 gene in families with JBTS5 localized the phenotype to 12q21.32 (Sayer et al., 2006; Valente et al., 2006).


Molecular Genetics

Upon mutation analysis within the NPHP6 genetic interval, Sayer et al. (2006) identified an identical homozygous nonsense mutation, 5668G-T (G1890X), located in the CEP290 gene (610142.0001), which had been described as a component of the centrosomal proteome (Andersen et al., 2003), in 2 kindreds. Further mutation screening in 96 unrelated individuals with JBTS by direct sequencing identified this mutation in a third family. Altogether Sayer et al. (2006) identified 8 distinct mutations in CEP290 in 7 JBTS families.

In 5 families with JBTS, Valente et al. (2006) found 5 mutations in the CEP290 gene, including 3 nonsense mutations resulting in premature protein truncation, one 1-bp deletion generating a frameshift and a premature stop codon, and 1 missense mutation (W7C; 610142.0003).


REFERENCES

  1. Andersen, J. S., Wilkinson, C. J., Mayor, T., Mortensen, P., Nigg, E. A., Mann, M. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426: 570-574, 2003. [PubMed: 14654843, related citations] [Full Text]

  2. Bachmann-Gagescu, R., Dempsey, J. C., Phelps, I. G., O'Roak, B. J., Knutzen, D. M., Rue, T. C., Ishak, G. E., Isabella, C. R., Gorden, N., Adkins, J., Boyle, E. A., de Lacy, N., and 17 others. Joubert syndrome: a model for untangling recessive disorders with extreme genetic heterogeneity. J. Med. Genet. 52: 514-522, 2015. [PubMed: 26092869, images, related citations] [Full Text]

  3. Gleeson, J. G., Keeler, L. C., Parisi, M. A., Marsh, S. E., Chance, P. F., Glass, I. A., Graham, J. M., Jr., Maria, B. L., Barkovich, A. J., Dobyns, W. B. Molar tooth sign of the midbrain-hindbrain junction: occurrence in multiple distinct syndromes. Am. J. Med. Genet. 125A: 125-134, 2004. [PubMed: 14981712, related citations] [Full Text]

  4. Sayer, J. A., Otto, E. A., O'Toole, J. F., Nurnberg, G., Kennedy, M. A., Becker, C., Hennies, H. C., Helou, J., Attanasio, M., Fausett, B. V., Utsch, B., Khanna, H., and 30 others. The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4. Nature Genet. 38: 674-681, 2006. [PubMed: 16682973, related citations] [Full Text]

  5. Utsch, B., Sayer, J. A., Attanasio, M., Pereira, R. R., Eccles, M., Hennies, H.-C., Otto, E. A., Hildebrandt, F. Identification of the first AHI1 gene mutations in families with Joubert syndrome and nephronophthisis. Pediat. Nephrol. 21: 32-35, 2006. [PubMed: 16240161, related citations] [Full Text]

  6. Valente, E. M., Silhavy, J. L., Brancati, F., Barrano, G., Krishnaswami, S. R., Castori, M., Lancaster, M. A., Boltshauser, E., Boccone, L., Al-Gazali, L., Fazzi, E., Signorini, S., Louie, C. M., Bellacchio, E., International Joubert Syndrome Related Disorders (JSRD) Study Group, Bertini, E., Dallapiccola, B., Gleeson, J. G. Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome. Nature Genet. 38: 623-625, 2006. [PubMed: 16682970, related citations] [Full Text]


Contributors:
Cassandra L. Kniffin - updated : 12/2/2015
Creation Date:
Anne M. Stumpf : 6/14/2006
alopez : 02/16/2024
carol : 03/06/2018
carol : 11/06/2017
carol : 12/03/2015
ckniffin : 12/2/2015
wwang : 9/25/2008
terry : 11/3/2006
alopez : 6/14/2006

# 610188

JOUBERT SYNDROME 5; JBTS5


ORPHA: 2318, 475;   DO: 0111000;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
12q21.32 Joubert syndrome 5 610188 Autosomal recessive 3 CEP290 610142

TEXT

A number sign (#) is used with this entry because of evidence that Joubert syndrome-5 (JBTS5) is caused by homozygous or compound heterozygous mutation in the gene encoding the centrosomal protein CEP290 (610142) on chromosome 12q21.

For a phenotypic description and a discussion of genetic heterogeneity of Joubert syndrome, see 213300.


Clinical Features

Joubert syndrome (JBTS) is an autosomal recessive disorder presenting with psychomotor delay, hypotonia, ataxia, oculomotor apraxia, and neonatal breathing abnormalities (Valente et al., 2006). Neuroradiologically, Joubert syndrome is characterized by a peculiar malformation of the midbrain-hindbrain junction known as the 'molar tooth sign' (MTS) consisting of cerebellar vermis hypoplasia or aplasia, thick and maloriented superior cerebellar peduncles, and abnormally deep interpeduncular fossa. A number of distinct syndromes sharing the MTS have been described, presenting wide phenotypic variability both within and among families (Gleeson et al., 2004).

Valente et al. (2006) described the JBTS5 phenotype as characterized mainly by the neurologic and neuroradiologic features of Joubert syndrome associated with severe retinal and renal involvement, but noted that the clinical spectrum was broad, including incomplete phenotypes such as cerebelloretinal and cerebellorenal syndromes. The full-blown JBTS5 phenotype largely overlaps that of Senior-Loken syndrome (SLSN; see 266900), which is characterized by retinitis pigmentosa plus juvenile nephronophthisis and is attributable to mutations in genes associated with nephronophthisis and encoding ciliary proteins.

In a comprehensive study of 279 patients from 232 unrelated families with Joubert syndrome in whom a genetic basis was determined by molecular analysis of 27 candidate genes, Bachmann-Gagescu et al. (2015) found a significant association between mutations in the CEP290 gene and retinal dystrophy (odds ratio (OR) of 22.9) and cystic kidney disease (OR of 3.3). None of 55 individuals with CEP290 mutations had seizures, suggesting a negative association with that feature.


Inheritance

The transmission pattern of JBTS5 in the families reported by Sayer et al. (2006) was consistent with autosomal recessive inheritance.


Mapping

In Joubert syndrome, nephronophthisis (NPHP) is combined with retinal degeneration, cerebellar vermis aplasia, and mental retardation. Identification of 5 genes mutated in NPHP implicated primary cilia, basal bodies, and mechanisms of plantar cell polarity in the pathogenesis of renal cystic disease. In a worldwide cohort including 90 individuals with JBTS, recessive mutations in known NPHP-associated genes were found in only 1% of JBTS cases (Utsch et al., 2006). To identify further causative genes for NPHP, Sayer et al. (2006) performed a whole-genome search for linkage by homozygosity mapping in 25 consanguineous kindreds with NPHP, SLSN, or JBTS, ascertained worldwide, each of which had 2 affected individuals and was negative for mutations in known NPHP genes. Three kindreds showed an overlap of nonparametric lod score (NPL) peaks on 12q indicating potential homozygosity by descent. Refinement of the linkage narrowed the region to 12q21.32-q21.33.

Valente et al. (2006) identified the JBTS5 locus on 12q21.31-q21.33 in linkage analysis from consanguineous families with Joubert syndrome-related disorders (JSRDs), which showed the neurologic features of Joubert syndrome associated with multiorgan involvement (mainly retinal dystrophy and nephronophthisis).

Identification of causative mutations in the CEP290 gene in families with JBTS5 localized the phenotype to 12q21.32 (Sayer et al., 2006; Valente et al., 2006).


Molecular Genetics

Upon mutation analysis within the NPHP6 genetic interval, Sayer et al. (2006) identified an identical homozygous nonsense mutation, 5668G-T (G1890X), located in the CEP290 gene (610142.0001), which had been described as a component of the centrosomal proteome (Andersen et al., 2003), in 2 kindreds. Further mutation screening in 96 unrelated individuals with JBTS by direct sequencing identified this mutation in a third family. Altogether Sayer et al. (2006) identified 8 distinct mutations in CEP290 in 7 JBTS families.

In 5 families with JBTS, Valente et al. (2006) found 5 mutations in the CEP290 gene, including 3 nonsense mutations resulting in premature protein truncation, one 1-bp deletion generating a frameshift and a premature stop codon, and 1 missense mutation (W7C; 610142.0003).


REFERENCES

  1. Andersen, J. S., Wilkinson, C. J., Mayor, T., Mortensen, P., Nigg, E. A., Mann, M. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426: 570-574, 2003. [PubMed: 14654843] [Full Text: https://doi.org/10.1038/nature02166]

  2. Bachmann-Gagescu, R., Dempsey, J. C., Phelps, I. G., O'Roak, B. J., Knutzen, D. M., Rue, T. C., Ishak, G. E., Isabella, C. R., Gorden, N., Adkins, J., Boyle, E. A., de Lacy, N., and 17 others. Joubert syndrome: a model for untangling recessive disorders with extreme genetic heterogeneity. J. Med. Genet. 52: 514-522, 2015. [PubMed: 26092869] [Full Text: https://doi.org/10.1136/jmedgenet-2015-103087]

  3. Gleeson, J. G., Keeler, L. C., Parisi, M. A., Marsh, S. E., Chance, P. F., Glass, I. A., Graham, J. M., Jr., Maria, B. L., Barkovich, A. J., Dobyns, W. B. Molar tooth sign of the midbrain-hindbrain junction: occurrence in multiple distinct syndromes. Am. J. Med. Genet. 125A: 125-134, 2004. [PubMed: 14981712] [Full Text: https://doi.org/10.1002/ajmg.a.20437]

  4. Sayer, J. A., Otto, E. A., O'Toole, J. F., Nurnberg, G., Kennedy, M. A., Becker, C., Hennies, H. C., Helou, J., Attanasio, M., Fausett, B. V., Utsch, B., Khanna, H., and 30 others. The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4. Nature Genet. 38: 674-681, 2006. [PubMed: 16682973] [Full Text: https://doi.org/10.1038/ng1786]

  5. Utsch, B., Sayer, J. A., Attanasio, M., Pereira, R. R., Eccles, M., Hennies, H.-C., Otto, E. A., Hildebrandt, F. Identification of the first AHI1 gene mutations in families with Joubert syndrome and nephronophthisis. Pediat. Nephrol. 21: 32-35, 2006. [PubMed: 16240161] [Full Text: https://doi.org/10.1007/s00467-005-2054-y]

  6. Valente, E. M., Silhavy, J. L., Brancati, F., Barrano, G., Krishnaswami, S. R., Castori, M., Lancaster, M. A., Boltshauser, E., Boccone, L., Al-Gazali, L., Fazzi, E., Signorini, S., Louie, C. M., Bellacchio, E., International Joubert Syndrome Related Disorders (JSRD) Study Group, Bertini, E., Dallapiccola, B., Gleeson, J. G. Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome. Nature Genet. 38: 623-625, 2006. [PubMed: 16682970] [Full Text: https://doi.org/10.1038/ng1805]


Contributors:
Cassandra L. Kniffin - updated : 12/2/2015

Creation Date:
Anne M. Stumpf : 6/14/2006

Edit History:
alopez : 02/16/2024
carol : 03/06/2018
carol : 11/06/2017
carol : 12/03/2015
ckniffin : 12/2/2015
wwang : 9/25/2008
terry : 11/3/2006
alopez : 6/14/2006